Search for: "Aventis Pharmaceuticals, Inc." Results 41 - 60 of 219
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Sep 2007, 2:00 pm
See Aventis Pharma Deutschland Gmbh and King Pharmaceuticals, Inc., v. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
25 Aug 2017, 7:02 am by Fraud Fighters
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
13 Sep 2008, 4:35 am
• Teva Pharmaceutical Industries Inc. spent $490,000... [read post]
15 Jun 2014, 8:46 pm by Patent Docs
.; Glenmark Generics Inc., USA • Defendant: Ferring, B.V. [read post]
5 Sep 2017, 7:45 am by Ben Vernia
According to DOJ’s press release: Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed primarily to Medicaid, the Justice Department announced today. [read post]
24 Apr 2014, 9:59 pm by Patent Docs
By Michael Greenfield -- On April 21, 2014, a Federal Circuit panel reiterated its interpretation and application to the chemical arts of the KSR obviousness standard. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
2 Apr 2011, 11:58 pm
Sanofi-Aventis sued Sun Pharmaceutical for its generic mimic of a cancer treatment drug, oxaliplatin. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
16 Jun 2010, 2:04 am by gmlevine
Pharmaceuticals (Sanofi-Aventis), banks and finance (Citigroup, Inc., MasterCard International Incorporated) , fashion (Christian Dior Couture), retail (Harrods Limited, Burberry Limited), hotels and travel (Sheraton International Inc.), automobiles (Bayerische Motoren Werke AG (BMW AG)) and toy manufacturers (LEGO Juris A/S) are frequent targets. [read post]
27 Sep 2020, 6:36 pm by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/21: Aventis Pharama S.A., Sanofi-Aventis US LLC v. [read post]
17 Jan 2007, 5:24 am
The companies that have been sued to date are Amgen, Inc.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
16 Sep 2011, 11:02 am by eithurburn@getnicklaw.com
  The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]